CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
The objective of the study is to constrcut a noninvasive approach 124I-18B10(10L) PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from CLDN18.2 targeting treatment.
Gastrointestinal Cancer
OTHER: 124I-18B10(10L) PET/CT
Standardized uptake value（SUV）, 2 years
The objective of the study is to constrcut a noninvasive approach 124I-18B10(10L) PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from CLDN18.2 targeting treatment.